Latest News

Deadly bacteria in recalled eye drops can spread person-to-person


 

Contaminated, deadly, and blindness-causing eyedrops that were recalled earlier this year were made in India at a factory not inspected by the U.S. Food and Drug Administration, according to a new report.

Scientists are concerned that the once-rare treatment-resistant bacteria found in the eyedrops can spread person-to-person, posing a risk of becoming a recurrent problem in the United States, The New York Times reported.

In January, EzriCare and Delsam Pharma artificial tears and ointment products were recalled after being linked to the bacterium P. aeruginosa. The bacteria have caused at least 68 infections, including three deaths and at least eight cases of blindness. The eyedrops were imported to the United States from India, and many of the cases occurred after the bacteria spread person-to-person at a long-term care facility in Connecticut, according to the Times, which cited FDA and Centers for Disease Control and Prevention lead investigator Maroya Walters, PhD.

Dr. Walters said the cases that caused death or blindness were traced to the EzriCare artificial tears product.

“It’s very hard to get rid of,” University of North Carolina at Chapel Hill infectious disease specialist David van Duin, MD, PhD, told the Times, noting that the bacteria cling to sink drains, water faucets, and other moist places.

The FDA said it had halted the import of the recalled products and has since visited the plant in India where they were made, which is owned by Global Pharma Healthcare. In a citation to the company dated March 2, the FDA listed nearly a dozen problems, such as dirty equipment and the absence of safety procedures and tests.

A version of this article originally appeared on WebMD.com.

Recommended Reading

HIV testing still suboptimal
MDedge Family Medicine
COVID can mimic prostate cancer symptoms
MDedge Family Medicine
Old-school printer helps scientists quickly spot bacteria in blood
MDedge Family Medicine
Cases of potentially deadly fungus jump 200%: CDC
MDedge Family Medicine
Tyrosine kinase inhibitors – a new weapon against respiratory viruses?
MDedge Family Medicine
Celebrity death finally solved – with locks of hair
MDedge Family Medicine
Expert shares her tips for diagnosing, treating onychomycosis
MDedge Family Medicine
eNose knows S. aureus in children with cystic fibrosis
MDedge Family Medicine
Spotting STIs: Vaginal swabs work best
MDedge Family Medicine
High-dose prophylactic anticoagulation benefits patients with COVID-19 pneumonia
MDedge Family Medicine